Ascendis Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug.

CEO

Jan Møller Mikkelsen

CEOJan Møller Mikkelsen

Employees

—

Employees—

Headquarters

Hellerup, Capital Region

HeadquartersHellerup, Capital Region

Founded

2006

Founded2006

Employees

—

Employees—

ASND Key Statistics

Market cap

7.75B

Market cap7.75B

Price-Earnings ratio

-14.79

Price-Earnings ratio-14.79

Dividend yield

—

Dividend yield—

Average volume

295.44K

Average volume295.44K

High today

$140.01

High today$140.01

Low today

$136.19

Low today$136.19

Open price

$140.01

Open price$140.01

Volume

364.80K

Volume364.80K

52 Week high

$161.00

52 Week high$161.00

52 Week low

$66.03

52 Week low$66.03

ASND News

TipRanks 2d

Ascendis Pharma Gains UK Authorization for YORVIPATH - TipRanks.com - TipRanks

Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S has achieved a significant milestone by obtaining marketing authorization from the UK’s...

TipRanks 2d

Ascendis Pharma announces MRHA approval of YORVIPATH in Great Britain

Ascendis Pharma announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency has granted marketing authorization for YORVIPATH in Great...

Analyst ratings

85%

of 13 ratings

Buy

84.6%

Hold

15.4%

Sell